Al-Absi et al. demonstrated that plasma LCN2 levels were not affected by diabetes, suggesting that observed changes in T2DM patients may be due to obesity rather than the diabetic state [26]. Here, LCN2 is linked to obesity due to melanocortin 4 receptor deficiency.